Jill DeSimone - Jan 4, 2023 Form 3 Insider Report for Oncternal Therapeutics, Inc. (ONCT)

Role
Director
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Stock symbol
ONCT
Transactions as of
Jan 4, 2023
Transactions value $
$0
Form type
3
Date filed
1/5/2023, 05:01 PM
Previous filing
May 24, 2022
Next filing
Mar 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ONCT Stock Option Jan 4, 2023 Common Stock 10K $1.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest in 24 equal monthly installments with the first installment vesting on July 22, 2022, subject to the recipient's continued service.

Remarks:

Exhibit 24 - Power of Attorney